Exposure Keratopathy – Comprehensive Medical Guide

Overview

Exposure keratopathy (also called exposure keratitis or ocular surface disease due to lagophthalmos) is a condition in which the cornea becomes damaged because it is not adequately protected by the eyelids. When the eye cannot close fully, the corneal surface is exposed to the air, leading to drying, inflammation, and epithelial breakdown.

It can affect anyone, but it is most common in:

• Older adults (especially > 65 years) because of reduced lid tone and blink reflex.
• Patients with facial nerve palsy, Bell’s palsy, or after stroke.
• Individuals with eyelid disorders (e.g., ectropion, entropion, ptosis).
• Those who undergo prolonged sedation or mechanical ventilation in intensive‑care settings.

Exact prevalence is difficult to estimate, but studies of intensive‑care units report exposure keratopathy in 20–30 % of intubated patients. In the general outpatient population, the condition is less frequent, occurring in roughly 1–2 % of patients with chronic facial nerve palsy.

Symptoms

The clinical picture varies from mild irritation to severe corneal ulceration. Common symptoms include:

• Foreign‑body sensation – feeling like something is in the eye.
• Burning or stinging pain – often worse in dry environments or after waking.
• Redness (conjunctival injection) – usually diffuse, may be more pronounced near the cornea.
• Tearing (epiphora) – paradoxical increase in tearing as the eye tries to compensate for dryness.
• Blurred vision – transient; improves with blinking or lubrication.
• Photophobia – sensitivity to light, especially bright indoor lighting.
• Crusting or discharge – especially upon waking.
• Decreased blink reflex – patients may not notice the problem until the cornea is visibly damaged.
• Visible corneal defects – epithelial erosions or ulcerations seen on slit‑lamp exam.

Causes and Risk Factors

Primary Mechanisms

Exposure keratopathy results when the protective barrier formed by the eyelids is compromised, leading to:

• Lagophthalmos – incomplete eyelid closure (partial or total).
• Reduced tear film stability – dryness accelerates epithelial breakdown.
• Increased evaporative loss – especially in low‑humidity environments.

Common Causes

• Neurologic injury – facial nerve palsy, stroke, traumatic brain injury.
• Eyelid malposition – ectropion (outward turning), entropion (inward turning), ptosis, or blepharoptosis.
• Systemic diseases – myasthenia gravis, Graves’ ophthalmopathy, dermatologic conditions causing scarring.
• Surgical factors – blepharoplasty complications, orbital surgery, or cataract surgery under retro‑bulbar block causing temporary lagophthalmos.
• Prolonged sedation/intubation – patients cannot blink fully.
• Medications – anticholinergics, antihistamines, and some antidepressants reduce tear production.

Risk Enhancers

• Advanced age
• Diabetes mellitus (reduces corneal sensitivity)
• History of dry eye disease or Sjögren’s syndrome
• Contact lens wear (especially if lenses are worn while sleeping)
• Exposure to wind, air conditioning, or heating vents

Diagnosis

Diagnosis is clinical, based on history and physical examination, but several tests help confirm severity.

History & Physical Exam

• Ask about facial weakness, recent surgeries, sedation, or neurologic events.
• Assess blink completeness by asking the patient to close eyes gently and observing any residual gap.
• Look for corneal staining with fluorescein dye under a cobalt‑blue filter.

Diagnostic Tests

• Fluorescein Staining – highlights epithelial defects; graded using the Oxford or NEI scale.
• Schirmer Test – measures tear production; values <5 mm/5 min indicate severe dryness.
• Tear Break‑Up Time (TBUT) – time for dry spots to appear after blinking; <10 seconds is abnormal.
• Corneal Topography or OCT – evaluates depth of epithelial loss, especially if ulceration is suspected.
• Blink Reflex Testing – neuro‑ophthalmologic assessment for facial nerve function.

Treatment Options

Treatment aims to restore a healthy ocular surface, protect the cornea, and address the underlying cause.

Lubrication & Protective Measures

• Artificial Tears – preservative‑free drops every 1–2 hours while awake.
• Ocular Gels/Ointments – thicker lubricants (e.g., carboxymethylcellulose 1 % gel or petrolatum‑based ointment) at bedtime.
• Moisture‑Chamber Goggles – create a humid micro‑environment; especially useful for nocturnal lagophthalmos.
• Eyelid Taping – gentle tape (e.g., surgical tape) to keep lids closed during sleep; must be taught by a clinician to avoid pressure injury.

Medical Therapy

• Topical Antibiotics – prophylactic use if epithelial breakdown is present (e.g., moxifloxacin QID).
• Topical Steroids – short courses to reduce inflammation, only under specialist supervision.
• Cyclosporine 0.05 % ophthalmic emulsion – improves tear production in chronic dry eye component.

Surgical/Procedural Interventions

• Temporary Tarsorrhaphy – suturing the eyelids partially together; reversible and often used in acute cases.
• Permanent or Semi‑Permanent Tarsorrhaphy – indicated when lagophthalmos is persistent.
• Eyelid Weight Implants – gold or platinum weights placed in the upper lid to aid passive closure in facial nerve palsy.
• Botulinum Toxin Injection – into the levator palpebrae muscle to temporarily lower the lid.
• Amniotic Membrane Transplant – promotes epithelial healing in severe ulceration.

Addressing Underlying Causes

• Physical therapy for facial nerve recovery.
• Management of systemic disease (e.g., control of Graves’ disease, diabetes optimization).
• Medication review to discontinue or substitute drugs that worsen dryness.

Living with Exposure Keratopathy

Daily habits can substantially improve comfort and prevent progression.

• Regular Lubrication – keep a bottle of preservative‑free drops at work, home, and in the car.
• Humidify Indoor Air – use a humidifier especially in winter.
• Protective Eyewear – wrap‑around glasses in windy conditions or when cleaning with chemicals.
• Sleep Hygiene – ensure eyelids stay closed: use a moisture chamber or taping as instructed.
• Avoid Smoke & Irritants – cigarette smoke and strong fumes exacerbate dryness.
• Nutrition – omega‑3 fatty acids (e.g., fish oil) may improve tear film quality.
• Follow‑up Visits – regular ophthalmology appointments (every 3–6 months) to monitor corneal health.

Prevention

Preventive strategies focus on minimizing exposure and maintaining tear film integrity.

• Early detection of facial nerve weakness; start eye protection promptly.
• Use of lubricating eye drops before any anticipated period of reduced blinking (e.g., long flights).
• Prompt treatment of eyelid malpositions with an oculoplastic surgeon.
• Review medications annually with a pharmacist or physician.
• Educate caregivers of ICU patients about the need for eye closure checks every 2–4 hours.

Complications

If left untreated, exposure keratopathy can lead to serious ocular sequelae:

• Corneal Ulceration – deep epithelial loss that may become infected.
• Scarring (Corneal Opacities) – can cause permanent visual impairment.
• Secondary Glaucoma – due to inflammation or steroid use.
• Vision Loss – rare but possible with extensive scarring or perforation.
• Infectious Keratitis – bacterial, fungal, or viral superinfection requiring aggressive treatment.

When to Seek Emergency Care

© 2026 HealthGuide.org – All information provided is for educational purposes only and does not replace professional medical advice. If you suspect you have exposure keratopathy, schedule an appointment with an ophthalmologist or optometrist promptly.